Cargando…

Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support

INTRODUCTION: COVID-19 can lead to acute respiratory failure (ARF) requiring admission to intensive care unit (ICU). This study analyzes COVID-19 patients admitted to the ICU, according to the initial respiratory support. Its main aim is to determine if the use of combination therapy: high-flow oxyg...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrillo-Alcaraz, Andrés, Guia, Miguel, Lopez-Gomez, Laura, Bayoumy, Pablo, Alonso-Fernández, Nuria, Martínez-Quintana, Maria Elena, Higon-Cañigral, Aurea, Renedo-Villarroya, Ana, Sánchez-Nieto, Juan Miguel, Del Baño, Maria Dolores
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783099/
http://dx.doi.org/10.1016/j.tacc.2022.101208
_version_ 1784857497409945600
author Carrillo-Alcaraz, Andrés
Guia, Miguel
Lopez-Gomez, Laura
Bayoumy, Pablo
Alonso-Fernández, Nuria
Martínez-Quintana, Maria Elena
Higon-Cañigral, Aurea
Renedo-Villarroya, Ana
Sánchez-Nieto, Juan Miguel
Del Baño, Maria Dolores
author_facet Carrillo-Alcaraz, Andrés
Guia, Miguel
Lopez-Gomez, Laura
Bayoumy, Pablo
Alonso-Fernández, Nuria
Martínez-Quintana, Maria Elena
Higon-Cañigral, Aurea
Renedo-Villarroya, Ana
Sánchez-Nieto, Juan Miguel
Del Baño, Maria Dolores
author_sort Carrillo-Alcaraz, Andrés
collection PubMed
description INTRODUCTION: COVID-19 can lead to acute respiratory failure (ARF) requiring admission to intensive care unit (ICU). This study analyzes COVID-19 patients admitted to the ICU, according to the initial respiratory support. Its main aim is to determine if the use of combination therapy: high-flow oxygen system with nasal cannula (HFNC) and non-invasive ventilation (NIV), is effective and safe in the treatment of these patients. METHODS: Retrospective observational study with a prospective database. All COVID-19 patients, admitted to the ICU, between March 11, 2020, and February 12, 2022, and who required HFNC, NIV, or endotracheal intubation with invasive mechanical ventilation (ETI-IMV) were analyzed. HFNC failure was defined as therapeutic escalation to NIV, and NIV failure as the need for ETI-IMV or death in the ICU. The management of patients with non-invasive respiratory support included the use of combined therapy with different devices. The study period included the first six waves of the pandemic in Spain. RESULTS: 424 patients were analyzed, of whom 12 (2.8%) received HFNC, 397 (93.7%) NIV and 15 (3.5%) ETI-IMV as first respiratory support. PaO(2)/FiO(2) was 145 ± 30, 119 ± 26 and 117 ± 29 mmHg, respectively (p = 0.003). HFNC failed in 11 patients (91.7%), who then received NIV. Of the 408 patients treated with NIV, 353 (86.5%) received combination therapy with HFNC. In patients treated with NIV, there were 114 failures (27.9%). Only the value of SAPS II index (p = 0.001) and PaO(2)/FiO(2) (p < 0.001) differed between the six analyzed waves, being the most altered values in the 3rd and 6th waves. Hospital mortality was 18.7%, not differing between the different waves (p = 0.713). CONCLUSIONS: Severe COVID-19 ARF can be effectively and safely treated with NIV combined with HFNC. The clinical characteristics of the patients did not change between the different waves, only showing a slight increase in severity in the 3rd and 6th waves, with no difference in the outcome.
format Online
Article
Text
id pubmed-9783099
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-97830992022-12-23 Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support Carrillo-Alcaraz, Andrés Guia, Miguel Lopez-Gomez, Laura Bayoumy, Pablo Alonso-Fernández, Nuria Martínez-Quintana, Maria Elena Higon-Cañigral, Aurea Renedo-Villarroya, Ana Sánchez-Nieto, Juan Miguel Del Baño, Maria Dolores Trends in Anaesthesia & Critical Care Original Article INTRODUCTION: COVID-19 can lead to acute respiratory failure (ARF) requiring admission to intensive care unit (ICU). This study analyzes COVID-19 patients admitted to the ICU, according to the initial respiratory support. Its main aim is to determine if the use of combination therapy: high-flow oxygen system with nasal cannula (HFNC) and non-invasive ventilation (NIV), is effective and safe in the treatment of these patients. METHODS: Retrospective observational study with a prospective database. All COVID-19 patients, admitted to the ICU, between March 11, 2020, and February 12, 2022, and who required HFNC, NIV, or endotracheal intubation with invasive mechanical ventilation (ETI-IMV) were analyzed. HFNC failure was defined as therapeutic escalation to NIV, and NIV failure as the need for ETI-IMV or death in the ICU. The management of patients with non-invasive respiratory support included the use of combined therapy with different devices. The study period included the first six waves of the pandemic in Spain. RESULTS: 424 patients were analyzed, of whom 12 (2.8%) received HFNC, 397 (93.7%) NIV and 15 (3.5%) ETI-IMV as first respiratory support. PaO(2)/FiO(2) was 145 ± 30, 119 ± 26 and 117 ± 29 mmHg, respectively (p = 0.003). HFNC failed in 11 patients (91.7%), who then received NIV. Of the 408 patients treated with NIV, 353 (86.5%) received combination therapy with HFNC. In patients treated with NIV, there were 114 failures (27.9%). Only the value of SAPS II index (p = 0.001) and PaO(2)/FiO(2) (p < 0.001) differed between the six analyzed waves, being the most altered values in the 3rd and 6th waves. Hospital mortality was 18.7%, not differing between the different waves (p = 0.713). CONCLUSIONS: Severe COVID-19 ARF can be effectively and safely treated with NIV combined with HFNC. The clinical characteristics of the patients did not change between the different waves, only showing a slight increase in severity in the 3rd and 6th waves, with no difference in the outcome. Elsevier Ltd. 2023-02 2022-12-23 /pmc/articles/PMC9783099/ http://dx.doi.org/10.1016/j.tacc.2022.101208 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Article
Carrillo-Alcaraz, Andrés
Guia, Miguel
Lopez-Gomez, Laura
Bayoumy, Pablo
Alonso-Fernández, Nuria
Martínez-Quintana, Maria Elena
Higon-Cañigral, Aurea
Renedo-Villarroya, Ana
Sánchez-Nieto, Juan Miguel
Del Baño, Maria Dolores
Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support
title Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support
title_full Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support
title_fullStr Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support
title_full_unstemmed Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support
title_short Analysis of combined non-invasive respiratory support in the first six waves of the COVID-19 pandemic. Outcome according to the first respiratory support
title_sort analysis of combined non-invasive respiratory support in the first six waves of the covid-19 pandemic. outcome according to the first respiratory support
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783099/
http://dx.doi.org/10.1016/j.tacc.2022.101208
work_keys_str_mv AT carrilloalcarazandres analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT guiamiguel analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT lopezgomezlaura analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT bayoumypablo analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT alonsofernandeznuria analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT martinezquintanamariaelena analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT higoncanigralaurea analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT renedovillarroyaana analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT sancheznietojuanmiguel analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport
AT delbanomariadolores analysisofcombinednoninvasiverespiratorysupportinthefirstsixwavesofthecovid19pandemicoutcomeaccordingtothefirstrespiratorysupport